All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

Case Report: Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?

Stability-indicating methods for quantitative determination of zidovudine and stavudine in capsules

Stability-indicating methods for quantitative determination of zidovudine and stavudine in capsules

A Time to Event Analysis of Adverse Drug Reactions Due to Tenofovir, Zidovudine and Stavudine in a Cohort of Patients Receiving Antiretroviral Treatment at an Outpatient Clinic in Zimbabwe

Simultaneous quantification of zidovudine, stavudine, lamivudine and nevirapine by Micellar Electrokinetic Capillary Chromatography Quantification simultanée de zidovudine, stavudine, lamivudine et névirapine par chromatographie électrocinétique micellaire

Incidence of lactic acidosis toxicity among patients on stavudine or zidovudine containing antiretroviral therapy at Lighthouse clinics

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes

Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment

Risk adapted transmission prophylaxis to prevent vertical HIV–1 transmission: Effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine

Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

More...

COMPARISION OF EFFICACY OF STAVUDINE AND ZIDOVUDINE ON CD4 COUNTS IN TRIPLE DRUG THERAPY REGIMEN IN PATIENTS WITH HIV INFECTION - A RETROSPECTIVE STUDY

Keywords: HIV , Zidovudine , Stavudine , Lamivudine , nevirapine , CD4 Count.

Full-Text   Cite this paper   Add to My Lib

Abstract:

The main objective of the study is 1. To compare the effect of triple drug therapy with stavudine + lamivudine + nevirapine on CD4 counts 6months and 12 months after therapy. 2. To compare the effect of triple drug therapy with zidovudine + lamivudine + nevirapine on CD4 counts 6months and 12 months after therapy. 3. To compare the efficacy of the above two mentioned regimens. Methods: In this retrospective study, data was collected from the antiretroviral therapy (ART) Centre where 46 subjects infected with HIV received stavudine + lamivudine + nevirapine and 54 subjects infected with HIV received zidovudine + lamivudine + nevirapine. Baseline CD4 counts were recorded and compared with CD4 counts after 6 months and 12 months after therapy in each regimen. Changes in CD4 counts in both the regimen were also compared. Statistical analysis was done using ANOVA followed by Tukey test for group wise comparison. Results: Statistical analysis showed that there was no significant change in CD4 count after 6 months of treatment in stavudine group whereas there was significant increase in CD4 counts after 12 months after therapy with stavudine + lamivudine + nevirapine. But there was a significant increase in CD4 counts after both 6 months and 12 months of treatment with zidovudine + lamivudine + nevirapine. But when efficacy of both the regimen was compared with each other there was no significant change in the CD4 counts. Conclusion: This nevirapine and zidovudine + lamivudine + nevirapine are equally efficacious but improvement of CD4 counts after initial 6 months of therapy is better with zidovudine + lamivudine + nevirapine treated group than compared with stavudine + lamivudine + nevirapine treated group.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal